This is a non-core endpoint: only basic statistics are computed.
Brain astrocytoma
C3_ASTROCYTOMA
astrocytoma: A glial tumor of the brain or spinal cord showing astrocytic differentiation. It includes the following clinicopathological entities: pilocytic astrocytoma, diffuse astrocytoma, anaplastic astrocytoma, pleomorphic xanthoastrocytoma, subependymal giant cell astrocytoma, and glioblastoma.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditions
|
157 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
157 |
4. Check minimum number of eventsNone |
157 |
5. Include endpoints |
157 |
6. Filter based on genotype QC (FinnGen only) |
151 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
- Control conditions
- not HLP_C3_ASTROCYTOMA
Extra metadata
- Level in the ICD hierarchy
- C
- First used in FinnGen datafreeze
- DF8
Similar endpoints
↥List of similar endpoints to
Brain astrocytoma
based on the number of shared cases.
Similar with more cases:
- Brain astrocytoma, including Hilmo
- Brain glioblastoma and astrocytoma
- Malignant neoplasm of brain
- Malignant neoplasm of eye, brain and central nervous system
- Malignant neoplasm of brain, including Hilmo
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 151 | 73 | 78 |
| Unadjusted period prevalence (%) | 0.03 | 0.03 | 0.04 |
| Median age at first event (years) | 39.63 | 38.33 | 40.85 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 157
- Matched controls
- 1570
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
185.7
223.8
123
30
N03AX14
ATC
levetiracetam; systemic
239.0
193.9
95
10
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
193.9
174.7
87
10
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
71.7
166.3
114
56
130
Kela drug reimbursment
Malignant tumour
+∞
161.7
126
*
L01AX03
ATC
temozolomide; systemic
+∞
148.5
118
*
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
1626.4
146.3
120
*
H02AB02
ATC
dexamethasone; systemic
525.1
131.8
115
8
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
54.7
103.4
63
19
A04AA02
ATC
granisetron; systemic, transdermal
1949.3
102.1
88
*
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
84.1
100.6
55
10
C71.11
ICD-10 Finland
Malignant tumor of frontal lobe grade II glioma
+∞
88.0
76
*
A03FA01
ATC
metoclopramide; systemic, rectal
20.6
86.3
99
120
N03AF02
ATC
oxcarbazepine; oral
31.8
82.5
60
30
XX3DW
NOMESCO Finland
Time consuming IT work
33.3
78.2
55
25
WF002
NOMESCO Finland
Radical radiotherapy
1143.9
74.6
67
*
A04AA01
ATC
ondansetron; systemic, rectal
39.0
71.9
47
17
R56.8
ICD-10 Finland
Other and unspecified convulsions
23.0
69.4
58
39
C71.10
ICD-10 Finland
Malignant tumor in frontal lobe without histology
+∞
68.9
61
*
9400/3-C71.9
ICD-O-3
Astrocytoma, NOS, of brain, NOS
+∞
64.0
57
*
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
148.4
62.5
63
7
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
455.0
62.0
58
*
9400/3-C71.1
ICD-O-3
Astrocytoma, NOS, of frontal lobe
+∞
59.2
53
*
AA1AD
NOMESCO Finland
CT of head and brain
12.6
58.7
101
197
XA800
NOMESCO Finland
Neuropsychological investigation
19.9
58.1
51
37
C71.21
ICD-10 Finland
Malignant tumor of temporal lobe grade II glioma
+∞
54.4
49
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
53.2
48
*
G40.9
ICD-10 Finland
Epilepsy, unspecified
26.6
50.2
37
18
ZXC95
NOMESCO Finland
Use of surgical navigator
145.1
49.2
50
5
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
+∞
45.0
41
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
40.4
37
*
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
10.3
40.2
56
80
C71.20
ICD-10 Finland
Malignant tumor in temporal lobe without histology
+∞
36.9
34
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
+∞
34.7
32
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
7.7
32.9
62
123
Z51.5
ICD-10 Finland
Palliative care
66.1
31.9
36
7
N03AX18
ATC
lacosamide; systemic
79.6
29.2
32
5
9400/3-C71.2
ICD-O-3
Astrocytoma, NOS, of temporal lobe
+∞
27.9
26
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
323.5
27.6
27
*
WZC00
NOMESCO Finland
Treatment plan or consultation
5.8
27.2
90
295
AAG00
NOMESCO Finland
Stereotactic intracranial biopsy
+∞
26.8
25
*
C71.12
ICD-10 Finland
Malignant tumor of frontal lobe grade III glioma
+∞
26.8
25
*
ZXC40
NOMESCO Finland
Use of ultrasound
161.8
26.5
27
*
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
67.5
25.0
28
5
C71.1
ICD-10 Finland
Malignant neoplasm: Frontal lobe
+∞
24.6
23
*
C71.2
ICD-10 Finland
Malignant neoplasm: Temporal lobe
+∞
22.4
21
*
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
253.9
22.2
22
*
WX882
NOMESCO Finland
High dependency care
42.1
20.5
25
7
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
120.4
20.1
21
*
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
227.5
20.0
20
*
N03AG01
ATC
valproic acid; systemic, rectal
7.5
19.3
31
50
C71.90
ICD-10 Finland
Malignant tumor in unspecified localization in the brain without histology
+∞
19.1
18
*
D43.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified
+∞
19.1
18
*
N03AB02
ATC
phenytoin; systemic
42.2
18.2
22
6
C71.22
ICD-10 Finland
Malignant tumor of temporal lobe grade III glioma
+∞
18.1
17
*
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
33.3
18.0
23
8
YX8VG
NOMESCO Finland
Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy
+∞
17.0
16
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
189.3
16.8
17
*
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
34.3
16.6
21
7
A02BC02
ATC
pantoprazole; systemic
4.7
16.0
123
681
C71.31
ICD-10 Finland
Malignant tumor of the parietal lobe grand II glioma
+∞
15.9
15
*
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
+∞
15.9
15
*
WX402
NOMESCO Finland
General anaesthesia
4.2
15.1
53
170
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
88.6
14.9
16
*
ZX050
NOMESCO Finland
Stereotactic radiotherapy
+∞
14.8
14
*
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
164.7
14.7
15
*
N05BA09
ATC
clobazam; oral
30.6
14.7
19
7
N02AA05
ATC
oxycodone; systemic
5.5
14.5
32
70
ZXE20
NOMESCO Finland
More than three and less than five hours
5.5
14.5
32
70
WZC30
NOMESCO Finland
Teaching
4.9
14.3
37
93
C71.29
ICD-10 Finland
Malignant tumor in temporal lobe other or unspecified histology
+∞
13.7
13
*
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
+∞
13.7
13
*
C71.19
ICD-10 Finland
Malignant tumor of frontal lobe other or unspecified histology
+∞
12.7
12
*
WF029
NOMESCO Finland
Radiotherapy of local residive tumor
+∞
12.7
12
*
C71.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of brain
+∞
12.7
12
*
C71.01
ICD-10 Finland
Malignant tumor of cerebellum except lobes and ventricles grade II glioma
+∞
12.7
12
*
H53.4
ICD-10 Finland
Visual field defects
23.6
12.3
17
8
N03AF01
ATC
carbamazepine; oral, rectal
10.6
12.0
23
25
G40.10
ICD-10 Finland
Simple partial seizures
70.4
11.8
13
*
WX408
NOMESCO Finland
General anesthesy, balanced
3.5
11.7
53
198
C71.30
ICD-10 Finland
Malignant tumor in parietal lobe without histology
+∞
11.6
11
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
11.6
11
*
C71.23
ICD-10 Finland
Malignant tumor of temporal lobe grade IV glioma
+∞
11.6
11
*
R4150
NOMESCO Finland
Neuropsychological rehabilitation
18.9
11.5
17
10
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
10.5
10
*
C71.99
ICD-10 Finland
Malignant tumor in unspecified localization in the brain other or unspecified histology
+∞
10.5
10
*
AAA10
NOMESCO Finland
Biopsy through craniotomy
+∞
10.5
10
*
C71.13
ICD-10 Finland
Malignant tumor of frontal lobe grade IV glioma
+∞
10.5
10
*
ZXM40
NOMESCO Finland
Use of fluorescent substance
+∞
10.5
10
*
C71.81
ICD-10 Finland
Overall malignant tumor of the brain grade II glioma
+∞
10.5
10
*
WC105
NOMESCO Finland
Simple cytostatic therapy of local tumor recidive
+∞
10.5
10
*
N05CD08
ATC
midazolam; nasal, systemic
20.5
10.5
15
8
WX872
NOMESCO Finland
Intensive care
8.5
9.8
21
28
ZX090
NOMESCO Finland
Other technic of radiotherapy
58.7
9.8
11
*
N03AX23
ATC
brivaracetam; systemic
106.2
9.5
10
*
9400/3-C71.0
ICD-O-3
Astrocytoma, NOS, of cerebrum
+∞
9.5
9
*
AA1BD
NOMESCO Finland
Extensive CT of head and brain
16.9
9.2
14
9
183
Kela drug reimbursment
Lamotrigin and topiramate
15.2
8.9
14
10
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.2
8.8
41
154
R90.8
ICD-10 Finland
Other abnormal findings on diagnostic imaging of central nervous system
17.6
8.7
13
8
G91.1
ICD-10 Finland
Obstructive hydrocephalus
94.9
8.5
9
*
D43.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, unspecified
94.9
8.5
9
*
ZSA00
NOMESCO Finland
Procedure related to previous procedure classified in chapter A
+∞
8.4
8
*
ZXE30
NOMESCO Finland
More than five and less than seven hours
9.8
8.3
16
18
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
35.4
8.2
10
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.4
7.4
29
97
9400/3-C71.3
ICD-O-3
Astrocytoma, NOS, of parietal lobe
+∞
7.3
7
*
C71.00
ICD-10 Finland
Malignant tumor of the cerebrum except lobes and ventricles without histology
+∞
7.3
7
*
N76
ICPC
Neoplasm nervous system unspecified
+∞
7.3
7
*
R4120
NOMESCO Finland
Occupational therapy
4.5
7.3
19
47
G40
ICD-10 Finland
Epilepsy
14.7
7.0
11
8
R47.0
ICD-10 Finland
Dysphasia and aphasia
17.7
6.8
10
6
XX9BW
NOMESCO Finland
Submitting image material and/or investigation material to authority or other institution
23.7
6.8
9
*
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
23.7
6.8
9
*
D33.00
ICD-10 Finland
Medial pilosytic astrocytoma of the cerebrum
72.7
6.5
7
*
R4130
NOMESCO Finland
Speech therapy
8.7
6.5
13
16
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.1
6.5
31
117
H02AB09
ATC
hydrocortisone; systemic
9.9
6.4
12
13
Z73.3
ICD-10 Finland
Stress, not elsewhere classified
27.9
6.3
8
*
AA5NK
NOMESCO Finland
Tractography within white matter of central nervous system
+∞
6.3
6
*
A79
ICPC
Malignancy NOS
+∞
6.3
6
*
C71.80
ICD-10 Finland
Overall malignant tumor of the brain without histology
+∞
6.3
6
*
C71.91
ICD-10 Finland
Malignant tumor in unspecified location in the brain grade II glioma
+∞
6.3
6
*
C71.82
ICD-10 Finland
Overall malignant tumor of the brain grade III glioma
+∞
6.3
6
*
C71.40
ICD-10 Finland
Malignant tumor of the occipital lobe without histology
+∞
6.3
6
*
R4110
NOMESCO Finland
Physiotherapy
2.6
6.2
46
219
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.7
6.1
20
59
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
53
10
79.50
96.11
1.9
2.2
—
—
—
0
0
82
89
18.19
75.55
5.4
15.0
0.82
1.60
mmol/l
1.05
63
71
60
42
22.50
70.42
4.1
7.7
24.02
25.14
mmol/l
0.93
60
42
41
46
11.71
34.98
5.3
14.4
96.78
93.78
%
5.26
41
46
120
461
7.80
31.48
6.6
6.4
1.20
1.21
mmol/l
1.75
108
406
86
260
6.10
28.89
1.8
1.8
—
—
—
0
0
21
0
+∞
22.42
1.0
0.0
—
—
—
0
0
114
524
5.29
21.20
2.5
2.4
—
—
—
0
0
77
294
4.18
17.55
7.9
2.0
2.38
2.35
mmol/l
1.60
70
254
124
694
4.74
15.75
16.3
6.7
3.43
4.20
e9/l
4.14
105
607
86
401
3.53
13.76
4.0
8.9
1.04
1.20
inr
2.71
22
113
21
17
14.06
12.55
2.0
1.4
—
—
—
0
0
16
8
22.05
11.39
1.9
1.6
—
—
—
0
0
19
36
5.87
9.91
1.7
1.1
34.29
2.48
e6/l
1.22
14
27
8
0
+∞
8.40
1.1
0.0
—
—
—
0
0
101
1263
0.44
5.42
2.8
3.7
4.88
4.71
mmol/l
0.83
91
1197
101
1258
0.45
5.18
2.8
3.6
1.38
1.42
mmol/l
0.41
91
1190
103
1273
0.45
5.15
2.8
3.9
3.06
2.87
mmol/l
1.23
91
1199
61
382
1.98
3.98
2.6
2.8
13.30
36.90
ng/l
1.90
41
202
99
1212
0.50
3.93
2.7
3.3
1.34
1.27
mmol/l
0.32
89
1134
15
49
3.28
3.92
1.1
1.6
—
—
—
0
0
82
1059
0.53
3.76
3.3
3.7
—
—
—
0
0
13
38
3.64
3.40
1.4
1.6
—
—
—
0
0
24
112
2.35
3.27
8.8
6.0
—
—
—
0
0
28
141
2.20
3.20
1.6
1.6
—
—
—
0
0
8
19
4.38
2.71
1.1
1.2
—
—
—
0
0
8
19
4.38
2.71
1.1
1.2
—
—
—
0
0
5
7
7.33
2.56
1.0
1.0
—
—
—
0
0
20
96
2.24
2.56
1.5
1.6
—
—
—
0
0
141
1256
2.20
2.39
22.8
10.5
139.11
139.71
mmol/l
1.50
141
1223
12
47
2.68
2.33
3.5
2.7
1.22
1.22
mmol/l
0.26
12
39
141
1260
2.17
2.30
22.0
10.6
3.90
3.95
mmol/l
1.60
141
1224
28
160
1.91
2.29
2.6
2.3
4.28
2.53
e6/l
0.27
16
80
7
18
4.02
2.28
1.1
1.1
—
—
—
0
0
93
1104
0.61
2.26
3.1
4.6
35.74
38.58
mmol/mol
4.92
82
1053
101
1170
0.62
2.12
3.6
3.5
5.46
5.75
mmol/l
2.86
92
1084
28
165
1.85
2.09
2.6
2.2
0.69
0.73
e6/l
0.05
16
85
19
98
2.07
2.05
1.8
1.6
—
—
—
0
0
5
11
4.65
1.95
1.0
1.3
—
—
—
0
0
5
11
4.65
1.95
1.0
1.9
—
—
—
0
0
0
51
0.00
1.92
0.0
1.1
—
—
—
0
0
0
52
0.00
1.92
0.0
1.1
—
—
—
0
0
19
327
0.52
1.91
1.6
1.6
—
—
—
0
0
9
34
2.74
1.90
1.2
1.7
—
—
—
0
0
5
12
4.26
1.83
1.6
1.3
—
—
—
0
0
8
29
2.85
1.82
3.0
2.3
3.09
4.03
g/l
—
8
29
131
1168
1.73
1.79
19.6
8.3
99.52
92.45
ml/min/173m2
4.26
116
913
6
142
0.40
1.62
1.2
1.5
—
—
—
0
0
40
286
1.53
1.46
2.5
2.4
0.15
0.21
e6/l
0.30
29
215
9
39
2.39
1.45
2.0
1.8
112.67
92.85
%
—
9
39
5
17
3.00
1.37
1.2
1.4
—
—
—
0
0
0
38
0.00
1.36
0.0
1.2
—
15.87
—
0
6
0
37
0.00
1.36
0.0
1.4
—
—
—
0
0
48
362
1.47
1.35
2.4
2.4
—
—
—
0
0
139
1285
1.71
1.33
20.6
9.7
19.48
20.53
mg/l
0.20
130
961
0
41
0.00
1.33
0.0
1.5
—
—
—
0
0
30
205
1.57
1.33
2.0
3.2
1555.67
687.57
ng/l
0.22
12
132
8
34
2.42
1.31
2.8
2.1
225.13
175.35
%
—
8
34
8
34
2.42
1.31
1.1
1.7
—
—
—
0
0
5
18
2.83
1.29
1.2
1.4
—
—
—
0
0
141
1470
0.60
1.01
35.1
14.4
40.26
41.46
%
1.96
135
1397
8
139
0.55
0.88
1.1
2.0
—
—
—
0
0
21
291
0.68
0.87
1.8
2.2
—
—
—
0
0
142
1473
0.62
0.85
35.5
14.4
136.11
139.87
g/l
2.69
142
1452
24
320
0.70
0.81
1.9
2.3
—
—
—
0
0
15
219
0.65
0.80
1.3
1.5
—
—
—
0
0
0
25
0.00
0.80
0.0
1.1
—
—
—
0
0
11
172
0.61
0.79
2.3
2.4
0.65
0.75
ug/l
—
6
94
0
27
0.00
0.78
0.0
1.3
—
—
—
0
0
0
28
0.00
0.77
0.0
1.1
—
0.00
—
0
28
5
24
2.12
0.75
1.0
1.4
—
—
—
0
0
11
69
1.64
0.70
1.4
2.5
0.27
0.22
g/l
0.88
11
62
0
20
0.00
0.61
0.0
3.0
—
—
—
0
0
0
23
0.00
0.59
0.0
1.1
—
0.00
—
0
23
0
23
0.00
0.59
0.0
1.1
—
0.00
—
0
23
9
64
1.43
0.52
1.6
1.4
—
—
—
0
0
50
569
0.82
0.50
2.9
2.9
0.00
0.01
estimate
0.50
11
101
50
565
0.83
0.46
4.2
4.1
0.00
0.00
estimate
—
9
94
108
1141
0.83
0.46
3.8
4.3
1.64
1.74
mu/l
0.65
102
1064
51
572
0.84
0.43
2.9
3.0
0.00
0.00
estimate
—
9
92
11
79
1.42
0.42
3.5
2.7
—
—
—
0
0
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
0
15
0.00
0.41
0.0
2.4
—
—
—
0
0
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
0
19
0.00
0.39
0.0
1.5
—
7.81
—
0
19
9
68
1.34
0.38
1.7
1.3
18.59
21.95
iu/l
—
9
62
19
231
0.80
0.35
2.4
3.2
20.70
24.04
%
—
8
85
6
89
0.66
0.34
1.0
1.6
—
—
—
0
0
6
90
0.65
0.33
1.0
1.0
—
—
—
0
0
42
465
0.87
0.29
2.2
2.3
76.51
73.66
nmol/l
0.28
37
428
17
141
1.23
0.27
1.9
1.6
1369.33
1073.21
nmol/l
—
9
111
8
66
1.22
0.27
1.4
1.3
—
—
—
0
0
15
181
0.81
0.27
1.5
1.6
—
—
—
0
0
9
73
1.25
0.26
1.9
1.8
—
—
—
0
0
52
562
0.89
0.25
2.0
2.7
84.45
84.77
ug/l
0.01
46
531
6
84
0.70
0.24
1.0
1.4
—
—
—
0
0
6
84
0.70
0.24
1.0
1.4
—
—
—
0
0
6
84
0.70
0.24
1.0
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
0
12
0.00
0.21
0.0
1.8
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
153.46
—
0
12
15
176
0.84
0.21
1.3
2.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.5
—
7.57
—
0
13
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
0
14
0.00
0.20
0.0
1.7
—
—
—
0
0
141
1385
1.18
0.19
17.8
7.6
28.65
28.30
u/l
0.08
141
1345
42
452
0.90
0.18
3.2
2.8
—
—
—
0
0
26
286
0.89
0.16
3.1
3.2
0.00
0.00
estimate
—
9
94
9
78
1.16
0.15
1.7
2.3
8.77
10.14
ug/l
—
9
69
112
1145
0.92
0.13
29.1
11.7
13.32
14.32
%
6.78
112
1130
94
961
0.95
0.09
3.5
2.8
45.11
40.33
u/l
0.35
88
922
38
389
0.97
0.02
1.7
1.8
94.05
98.57
pmol/l
0.26
22
195
27
263
1.03
0.01
1.4
1.7
0.89
0.90
mg/l
0.01
16
194
15
149
1.01
0.00
2.1
2.3
11.90
6.46
umol/l
—
10
130
91
914
0.99
0.00
3.4
3.8
14.35
14.55
pmol/l
0.33
85
853
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
12
120
1.00
-0.00
3.9
3.7
24.86
30.92
%
—
7
79
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
6.84
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
3.9
—
—
—
0
0
5
49
1.02
-0.00
1.4
1.8
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
13.52
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
0.30
—
0
5
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
578.75
—
0
8
0
7
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_ASTROCYTOMA – Brain astrocytoma
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).